Back to search
FDAFDA · Food and drugs·Recall number D-0478-2017

Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-376-17

Published February 22, 2017 · Recall initiated: December 20, 2016

Summary

FDA records drug Class II recall D-0478-2017, published February 22, 2017 and initiated December 20, 2016. Recalling firm: Accord Healthcare, Inc.; Status: Terminated; Reported quantity: 12896 bottles; Lot: Lot # T04483, T04484, Exp 2/18; T06028, Exp 4/18; T08423, Exp 5/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed tablet/capsule specification: missing break line on the 5mg tablet.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Accord Healthcare, Inc.
Distributor
U.S. Nationwide and Puerto Rico
Lot
Lot # T04483, T04484, Exp 2/18; T06028, Exp 4/18; T08423, Exp 5/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-376-17 recalled?

Yes. FDA published recall D-0478-2017 on February 22, 2017. Reported hazard: Failed tablet/capsule specification: missing break line on the 5mg tablet.

What should I do if I have this product?

Voluntary: Firm initiated · Letter